Luis D. Franco-Jimenez

Saterland, NI 26683, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction: Susilo et al. Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. Pharmaceutics 2025, 17, 500.

Correction: Susilo et al. Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. Pharmaceutics 2025, 17, 500.

Journal: Pharmaceutics

Published: October 10, 2025

Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies.

Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies.

Journal: Pharmaceutics

Published: March 01, 2025

Automated and robust organ segmentation for 3D-based internal dose calculation.

Automated and robust organ segmentation for 3D-based internal dose calculation.

Journal: EJNMMI research

Published: February 04, 2021

Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma.

Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 26, 2020

Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases.

Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 26, 2020

Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC.

Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 21, 2020

Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99mTc imaging.

Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99mTc imaging.

Journal: Annals of nuclear medicine

Published: April 22, 2020

FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.

FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 13, 2020

Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.

Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 13, 2020

MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients.

MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 06, 2019

Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands.

Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands.

Journal: Nuclear medicine and biology

Published: February 05, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026